Not a direct competitor, but Orthocell (OCC) will be up today on US M&A activity - not cross promotion, I would not recommend buying any stock on a spike. But for PNV investors worth noting that US big Pharma (BioHorizons in this case, a top 5 dental implant company) are looking at Aussie bio-techs. That deal was in a collagen scaffold for tissue regeneration. Not entirely out of the sphere of PNV's products.
No way big Pharma is not looking at PNV's results and even more so its growing business at a very low market cap. I still think PNV is ripe for a takeover.
Not a direct competitor, but Orthocell (OCC) will be up today on...
-
- There are more pages in this discussion • 5,128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
-0.090(3.57%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.50 | $2.43 | $2.311M | 940.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17100 | $2.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.45 | 5973 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |